STOCK TITAN

Walker & Dunlop Inc SEC Filings

WD NYSE

Welcome to our dedicated page for Walker & Dunlop SEC filings (Ticker: WD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This page provides access to Walker & Dunlop, Inc. (NYSE: WD) filings with the U.S. Securities and Exchange Commission, along with AI-powered tools that help interpret the information. Walker & Dunlop is a Maryland corporation whose common stock is listed on the New York Stock Exchange, and its SEC reports offer detail on its commercial real estate finance and advisory activities.

Among the filings available are Form 8-K current reports, which the company uses to disclose material events. Recent 8-Ks describe press releases reporting quarterly and year-to-date financial results, amendments to a Master Repurchase Agreement and related side letters with JPMorgan Chase Bank, N.A., changes to the board of directors, and performance-based equity awards for senior executives. These documents shed light on Walker & Dunlop’s capital structure, financing facilities, governance, and compensation practices.

Investors can also review filings that detail repurchase facilities used by Walker & Dunlop and its operating subsidiary, Walker & Dunlop, LLC. Amendments to these agreements adjust facility amounts, fees, and termination dates, illustrating how the company structures secured financing to support its commercial real estate activities.

On Stock Titan, AI-generated summaries highlight key points from lengthy filings, helping users quickly identify items such as new credit arrangements, changes in directorships, or disclosures about financial results. As additional forms such as annual reports on Form 10-K, quarterly reports on Form 10-Q, and insider transaction reports on Form 4 are filed with the SEC, they can be incorporated into this page’s feed, with AI tools surfacing important terms, obligations, and governance details for easier review.

Rhea-AI Summary

Walker & Dunlop, Inc. officer EVP & Chief Operating Officer reported an equity-related transaction on 12/05/2025. The Form 4 shows the acquisition of 94.636 dividend equivalent rights, which the company states are economically equivalent to the same number of shares of its common stock.

The dividend equivalent rights were credited on restricted stock units already held by the executive and will vest proportionately with those underlying restricted stock units. After this transaction, the reporting person beneficially owned 1,292.685 dividend equivalent rights, held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.72%
Tags
insider
-
Rhea-AI Summary

Walker & Dunlop, Inc. executive vice president and Chief HR Officer reported a routine equity-related transaction. On 12/05/2025, the officer acquired 19.75 dividend equivalent rights, each economically equivalent to one share of Walker & Dunlop common stock. These rights accrued on restricted stock units already held by the officer and will vest proportionately with those restricted stock units.

After this transaction, the officer beneficially owned 65.657 derivative securities tied to Walker & Dunlop common stock. The dividend equivalent rights were acquired at a stated price of $0, reflecting their nature as an adjustment linked to existing restricted stock unit awards rather than an open-market purchase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.72%
Tags
insider
-
Rhea-AI Summary

Walker & Dunlop executive reports dividend equivalent rights

Walker & Dunlop, Inc. executive officer EVP, GC, Secretary & CCO filed a Form 4 reporting an equity-related transaction on 12/05/2025. The filing shows an acquisition (code "A") of 42.837 dividend equivalent rights, each economically equivalent to one share of Walker & Dunlop common stock, at a price of $0 per right.

The dividend equivalent rights accrued on restricted stock units already held by the executive and will vest proportionately with those underlying restricted stock units. Following this transaction, the executive beneficially owns 169.545 derivative securities of this type in direct ownership form.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.72%
Tags
insider
Rhea-AI Summary

Walker & Dunlop, Inc. executive vice president and chief financial officer reported an equity-related transaction involving derivative securities tied to the company’s common stock. On 12/05/2025, the officer acquired 24.451 dividend equivalent rights, each economically equivalent to one share of common stock, at a price of $0.

These dividend equivalent rights accrued on restricted stock units already held and will vest proportionately with those units over time. Following this transaction, the officer beneficially owned 99.938 derivative securities directly, reflecting ongoing alignment of compensation with the company’s equity performance rather than an open-market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.72%
Tags
insider
-
Rhea-AI Summary

Walker & Dunlop (WD) filed its Q3 2025 10‑Q, reporting total revenues of $337.7 million, up from $292.3 million a year ago. Net income was $33.5 million versus $28.8 million, with diluted EPS of $0.98 compared to $0.85. For the nine months, revenues reached $894.3 million and net income was $70.2 million.

Growth was broad-based: loan origination and debt brokerage fees were $97.8 million, servicing fees were $85.2 million, property sales broker fees were $26.5 million, and fair value of expected net cash flows from servicing added $48.7 million. MSRs carried a net value of $806.0 million after $52.3 million of quarterly amortization. The at-risk Fannie Mae servicing portfolio CECL allowance was $24.8 million with a forecast-period loss rate of 2.1 basis points in Q3.

Total assets were $5.80 billion (up from $4.38 billion at year-end), driven by loans held for sale of $2.20 billion. Warehouse notes payable increased to $2.18 billion. Servicing UPB was $139.3 billion. The company maintained $6.05 billion of Agency warehouse capacity with $2.18 billion outstanding, and had a $450 million term loan (balance $447.8 million) plus $400 million of Senior Notes hedged via a fair value swap tied to SOFR. Allowance for risk‑sharing obligations was $34.1 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.12%
Tags
quarterly report
-
Rhea-AI Summary

Walker & Dunlop, Inc. furnished an 8-K to report that it has issued a press release detailing its financial results for the quarter and year-to-date period ended September 30, 2025. The press release, dated November 6, 2025, is included as Exhibit 99.1 and is incorporated by reference into the results of operations and financial condition section. The company states that this information, including Exhibit 99.1, is being furnished rather than filed, meaning it is not automatically incorporated into Securities Act registration statements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.12%
Tags
current report
Rhea-AI Summary

Walker & Dunlop, Inc. amended its Master Repurchase Agreement with JPMorgan Chase Bank, N.A., extending the agreement's Termination Date to September 10, 2026. The company continues to guarantee the operating subsidiary Walker & Dunlop, LLC's obligations under the repurchase facility. A Side Letter dated September 11, 2025 updates fees, commitments and pricing, temporarily increasing the defined Facility Amount to $1,500,000,000 from September 11, 2025 through November 20, 2025, after which the Facility Amount will revert to $1,000,000,000 (previously $950,000,000). The Side Letter also revises the Non-Usage Fee definition and eliminates the Upfront Fee.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Walker & Dunlop, Inc. amended its Master Repurchase Agreement with JPMorgan Chase Bank, N.A., extending the agreement's Termination Date to September 10, 2026. The company continues to guarantee the operating subsidiary Walker & Dunlop, LLC's obligations under the repurchase facility. A Side Letter dated September 11, 2025 updates fees, commitments and pricing, temporarily increasing the defined Facility Amount to $1,500,000,000 from September 11, 2025 through November 20, 2025, after which the Facility Amount will revert to $1,000,000,000 (previously $950,000,000). The Side Letter also revises the Non-Usage Fee definition and eliminates the Upfront Fee.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Walker & Dunlop director Ernest Michael Freedman was granted 1,097 shares of restricted common stock on 09/11/2025 under the Walker & Dunlop, Inc. 2024 Equity Incentive Plan. The award was issued at no cash cost ($0 per share) and is reported as direct ownership of 1,097 shares following the grant. The restricted shares vest on May 1, 2026. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/15/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.06%
Tags
insider
Rhea-AI Summary

Walker & Dunlop director Ernest Michael Freedman was granted 1,097 shares of restricted common stock on 09/11/2025 under the Walker & Dunlop, Inc. 2024 Equity Incentive Plan. The award was issued at no cash cost ($0 per share) and is reported as direct ownership of 1,097 shares following the grant. The restricted shares vest on May 1, 2026. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/15/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.06%
Tags
insider
-
Rhea-AI Summary

Ernest Michael Freedman, identified as a director of Walker & Dunlop, Inc. (WD), submitted an initial Form 3 reporting that he does not beneficially own any securities of the issuer. The filing lists a company address and notes Exhibit 24 (Power of Attorney) was furnished and the form was executed by an attorney-in-fact. This is a routine Section 16 disclosure establishing the reporting obligation and confirming no direct or indirect holdings were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.06%
Tags
insider
-
Rhea-AI Summary

Ernest Michael Freedman, identified as a director of Walker & Dunlop, Inc. (WD), submitted an initial Form 3 reporting that he does not beneficially own any securities of the issuer. The filing lists a company address and notes Exhibit 24 (Power of Attorney) was furnished and the form was executed by an attorney-in-fact. This is a routine Section 16 disclosure establishing the reporting obligation and confirming no direct or indirect holdings were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.06%
Tags
insider
Rhea-AI Summary

Walker & Dunlop, Inc. expanded its board of directors from seven to eight members and elected Ernest M. Freedman as a director, effective September 11, 2025. He will serve until the next annual meeting of stockholders and continue until a successor is elected and qualified.

The board also appointed Mr. Freedman to its Audit and Risk Committee. He brings extensive real estate and finance experience, having served as Executive Vice President and Chief Financial Officer of Invitation Homes Inc. from 2015 to 2023 and previously as CFO of Apartment Investment and Management Company and HEI Hotels and Resorts. The board determined he is an independent director, meets the heightened independence standards for audit committee service, qualifies as an “audit committee financial expert,” and is considered financially literate under NYSE rules.

The company entered into an indemnification agreement with Mr. Freedman and will pay him the same cash and equity compensation as its other independent directors, pro-rated from his election date. Walker & Dunlop also issued a press release about his appointment, furnished as Exhibit 99.1.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

How many Walker & Dunlop (WD) SEC filings are available on StockTitan?

StockTitan tracks 55 SEC filings for Walker & Dunlop (WD), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Walker & Dunlop (WD)?

The most recent SEC filing for Walker & Dunlop (WD) was filed on December 9, 2025.